R Burcelin Selected Research

R Burcelin Research Topics

Disease

13	Insulin Resistance 02/2016 - 12/2000
10	Obesity 01/2017 - 03/2001
6	Type 2 Diabetes Mellitus (MODY) 01/2017 - 03/2006
6	Inflammation (Inflammations) 06/2015 - 05/2009
4	Hypoglycemia (Reactive Hypoglycemia) 08/2001 - 08/2000
3	Weight Loss (Weight Reduction) 01/2017 - 11/2012
3	Body Weight (Weight, Body) 02/2016 - 05/2009
2	Overweight 01/2017 - 02/2016
2	Hypertension (High Blood Pressure) 01/2017 - 07/2001
2	Weight Gain 06/2015 - 12/2014
2	Metabolic Diseases (Metabolic Disease) 06/2014 - 01/2013
2	Hyperinsulinism (Hyperinsulinemia) 07/2001 - 03/2001
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016
1	Neoplasms (Cancer) 05/2014
1	Heart Failure 04/2013
1	Fatty Liver 01/2011
1	Hypertrophy 05/2009
1	Body Weight Changes 12/2007
1	Fibrosis (Cirrhosis) 06/2007
1	Gram-Negative Bacterial Infections 06/2007
1	Hyperlipidemias (Hyperlipidemia) 07/2001
1	Renovascular Hypertension (Goldblatt Syndrome) 07/2001
1	Hyperphagia (Overeating) 03/2001
1	Glycosuria 08/2000
1	Hyperplasia 04/2000

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 04/2000
10	Insulin (Novolin)FDA Link 11/2012 - 08/2000
4	GlycogenIBA 05/2009 - 04/2000
3	LipopolysaccharidesIBA 12/2014 - 06/2007
2	CholesterolIBA 01/2017 - 07/2012
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2017 - 11/2012
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2017 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 06/2015 - 05/2014
2	Triglycerides (Triacylglycerol)IBA 06/2014 - 06/2007
2	Metformin (Glucophage)FDA LinkGeneric 05/2014 - 11/2012
2	LipidsIBA 04/2013 - 05/2009
2	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2013 - 08/2001
2	LeptinIBA 01/2011 - 03/2001
2	Glucagon (Glukagon)FDA Link 02/2008 - 08/2000
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2007 - 02/2003
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2000 - 10/2000
1	Liraglutide FDA Link 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2016
1	Blood Glucose (Blood Sugar)IBA 02/2016
1	Abatacept (Orencia)FDA Link 06/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2014
1	Biomarkers (Surrogate Marker)IBA 05/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 04/2013
1	Neuroprotective AgentsIBA 04/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2013
1	lipopolysaccharide-binding proteinIBA 11/2012
1	ImmunosorbentsIBA 11/2012
1	EnzymesIBA 11/2012
1	Transcription Factor CHOPIBA 04/2012
1	Ribosomal DNA (rDNA)IBA 12/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2011
1	Mitogen-Activated Protein Kinase 3IBA 01/2011
1	PPAR gammaIBA 05/2009
1	Rosiglitazone (Avandia)FDA Link 05/2009
1	AdiponectinIBA 05/2009
1	ThiazolidinedionesIBA 05/2009
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2009
1	CeramidesIBA 05/2009
1	Hormones (Hormone)IBA 02/2008
1	Phentolamine (Z-Max)FDA LinkGeneric 12/2007
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2007
1	benzylamineIBA 12/2007
1	Drinking WaterIBA 12/2007
1	Toll-Like Receptor 4IBA 06/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2001

Therapy/Procedure

2	Therapeutics 02/2016 - 04/2013
1	Bariatric Surgery 04/2013
1	Precision Medicine 01/2013
1	Complementary Therapies (Alternative Medicine) 05/2009
1	Surgical Instruments (Clip) 07/2001